King Pharmaceuticals KG Program Services — Net loss and loss adjustment expenses
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by King Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PolicyholderBenefitsAndClaimsIncurredNet.
The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about King Pharmaceuticals's program services — net loss and loss adjustment expenses.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is King Pharmaceuticals's program services — net loss and loss adjustment expenses?
- King Pharmaceuticals (KG) reported program services — net loss and loss adjustment expenses of $0 in Q1 2026.
- What does program services — net loss and loss adjustment expenses mean?
- The total costs incurred for claims and the associated expenses to investigate and settle those claims, net of reinsurance recoveries. This is a critical measure of the segment's underwriting quality and claims management efficiency.